Prof. Timothy Lyons is a graduate of the Queen’s University of Belfast. He trained in Internal Medicine in Belfast teaching hospitals and in Diabetes/Endocrinology at the Royal Victoria Hospital Metabolic Unit, and subsequently worked for 23 years in the United States, first at the Medical University of South Carolina, Charleston, South Carolina, and then at the University of Oklahoma Health Sciences Center in Oklahoma City. At the University of Oklahoma, he served as Professor of Medicine, Chief of the Section of Endocrinology, and as Director of the newly established Harold Hamm Diabetes Center. Throughout his time in the United States, he conducted laboratory, translational, and epidemiologic research in the complications of diabetes, while remaining active in clinical work and in the development of diabetes prevention programs. His laboratory was supported by NIH, as well as by funding from the American Diabetes Association, Juvenile Diabetes Research Foundation, and other agencies. His research included basic science, translational, and clinical studies to address the effects of modification of proteins and lipids in diabetes, and their implication in atherosclerosis, diabetic retinopathy, and complications of pregnancy. Ongoing epidemiologic studies have included 16 years collaboration with the Diabetes Control and Complications Trial (DCCT), and prospective studies of pre-eclampsia in pregnancy in women with both Type 1 and Type 2 diabetes, the latter in partnership with the Chickasaw and Choctaw Nations of Oklahoma. In 2013, he returned to Belfast to a Chair of Diabetes and Translational Medicine at the Queen's University, with the goal of developing a new, integrated translational Diabetes Research Programme.